Cargando…
Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab
Tocilizumab is a humanized monoclonal antibody targeting the interleukin-6 receptor that is frequently used for the treatment of refractory rheumatoid arthritis. Since patients with hepatitis B virus (HBV) infection were excluded from pivotal trials, the risk of HBV reactivation with this novel drug...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946203/ https://www.ncbi.nlm.nih.gov/pubmed/32042838 http://dx.doi.org/10.14309/crj.0000000000000243 |